Chlorotoxin-targeted CAR T cells for MMP2+ glioblastoma
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chlorotoxin-targeted CAR T cells for MMP2+ glioblastoma, covering 2025-10-06 to 2025-10-06. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma [Phase 1]